USFDA approval for Alembic's Ketorolac Tromethamine Inj
Uniindia: Mumbai, Nov 3 (UNI) Pharma major, Alembic Pharma on Thursday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials.
Source: uniindia.com